Welcome Message
Discover the Future of Vaccines at the World Conference on Vaccine and Immunology, a dynamic gathering pushing the boundaries of vaccine development. This year's theme, "Next-Gen Vaccines: Exploring mRNA Technologies and Tailored Immune Solutions" highlights transformative advancements in the field.
Join a global community of leading researchers, scientists, healthcare professionals, industry leaders, and government representatives over the next three days. Share groundbreaking discoveries, address critical challenges, and foster collaborations.
- Engage with thought leaders through keynote sessions, plenary talks, and presentations.
- Participate in interactive workshops, symposia, and exhibitions alongside peers from academia and industry.
Beyond the Conference - Explore the rich culture of the host city and take advantage of professional growth opportunities while broadening your global perspective.
Join us in shaping the future of vaccines! We are excitedly anticipating your active involvement in this engaging and fruitful conference.
About Vaccine 2024
Join us at the World Conference on Vaccine and Immunology, a hybrid event taking place from December 09-11, 2024, in Paris, France, organized by SciconX Conferences. You can choose to attend in person and experience the vibrant atmosphere of Paris, or participate virtually from the comfort of your own home or office.
This flexibility makes the conference accessible to a wider audience, fostering a dynamic exchange of ideas on the latest advancements in vaccines and immunology. This hybrid event explores "Next-Gen Vaccines" with a focus on mRNA technologies and tailored immune solutions.
Participants will share insights on cutting-edge breakthroughs in vaccines, particularly emphasizing mRNA technologies' role in developing new vaccines, including those for COVID-19. This collaborative exchange of ideas will propel the future of vaccine development and tailored immune solutions.
Vaccine and Immunology 2024: Unveiling the Latest Breakthroughs in Vaccine Development
This three-day conference unites a global community of experts from industry, academia, government, and regulatory agencies. They will share the latest advancements in vaccine research, address current challenges, and offer inspiring insights into the vaccine development process.
Vaccine and Immunology 2024 fosters a dynamic environment for interdisciplinary collaboration. Engage in discussions led by distinguished speakers and gain valuable lessons learned from the cutting edge of accelerated vaccine research.
This is your chance to be part of shaping the future of vaccines!
Our Brilliant Speakers
Sciconx is a leading conference organizer that helps you explore the future challenges of your industry and find innovative solutions. We connect you with the best speakers from around the world who have the expertise and experience to inspire and guide you. We also facilitate ideation sessions where you can design and validate new ideas with your end users. Whether you need a keynote, a workshop, or a panel discussion, we can help you find the right speaker for the right audience at the right time.
Gerardo Guillen
Hedwig Roggendorf
Ediane Batista Silva
Catherine Tsai
Ruqia Khan
Speaker Details
Gerardo Guillen
Gerardo Guillen is currently the Director of Biomedical Research at the Center for Genetic Engineering and Biotechnology (CIGB), Havana, Cuba. He received his Bachelor's degree in Chemistry and Master's in Chemistry in 1986 from I.I. Mechnikov University, Odessa, and his doctorate in Biological Sciences in 1995 from the University of Havana.
His research focuses on prophylactic and therapeutic vaccine development against hepatitis, dengue, meningitis, whooping cough, cancer, and COVID-19; and drug development.
Dr. Guillen is a Professor at the University of Havana and the Latin American School of Medicine. He has published 265 papers and 62 patents. He has been awarded the Biology Award from the TWAS, the Annual Award from the Cuban Society of Chemistry, and the Gold Medal for the Abdala vaccine patent granted by WIPO.
Speaker Details
Hedwig Roggendorf
Institute of Molecular Immunology1981 - 1988 Medical studies at LMU Munich /Jefferson University Philadelphia
1988 - 1990 research assistant at the Max von Pettenkofer Institute, Munich and doctorate
1991 - 2013 Essen University Hospital: Head of the vaccination consultation and
2000 - 2013 Essen Health Department: Deputy Head of the Pediatric and Adolescent Medical
Service with a focus on vaccination projects, e.g. vaccination education in schools and
increasing vaccination rates through vaccination advice and on-site vaccination. For this he
was awarded the Hufeland Prize 2012.
Since 2013 at the University Hospital Rechts der Isar, Munich: Head of the vaccination
/yellow fever vaccination center, teaching position “Prevention through vaccination” and
conducting vaccination studies with the main focus on Hepatitis B and SARS-CoV2.
Member of the State Vaccination Working Group (LAGI) in Bavaria,
the National Verification Committee (NVC) for the elimination of measles/rubella in Austria
and the Immunization Commission of the Society for Virology.
Speaker Details
Ediane Batista Silva
Ediane Silva studied Veterinary Medicine at the Federal University of Goias, Brazil and has a doctorate degree in Veterinary Medicine. Since 2021 she is a senior scientist at ARS FADRU as Veterinary Medical Officer (Clinical of African Swine Fever and Classical Swine Fever Program). She is also responsible for coordinate FADRU science transition from PIADC to NBAF. Ediane Silva has more than 20 years of experience working with infectious diasease and the last 8 years she has been dedicated to work with transboundry viruses under high containment conditions (BSL-3), including animal experiment and pathogenesis of food-and-mouth disease. Currently, her research focusses on clinical studies of ASF/CSF and undestanding ASF/CSF host immune response to vaccine candidates.
Speaker Details
Catherine Tsai
Speaker Details
Ruqia Khan
Ruqia Khan, a prominent researcher in marketing and consumer behavior, has made significant strides in understanding post-COVID-19 vaccine attitudes in Pakistan. Alongside her research on green consumption patterns, she has delved into developing distance-based learning platforms, particularly crucial during crises. Ruqia's interdisciplinary work has been published in esteemed journals, offering valuable insights into consumer behavior, public health, and sustainability. Her dedication extends beyond academia; she actively seeks to apply her findings to drive positive societal change. With a commitment to leveraging marketing insights for the greater good, Ruqia is recognized as a catalyst for progress in her field, shaping strategies and policies that contribute to more informed and resilient communities.
Media Partners
Social Media
Address
Sciconx, Kings Houxse,
17 Soho Square London W1D 3QJ,
United Kingdom
